These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2419352)

  • 1. Advances in the understanding of sickle cell anemia.
    Charache S
    Hosp Pract (Off Ed); 1986 Feb; 21(2):173-8, 182-90. PubMed ID: 2419352
    [No Abstract]   [Full Text] [Related]  

  • 2. Extracorporeal treatment of erythrocytes in sickle cell anemia: hemoglobin carbamylation.
    Diederich D; Curran M; Odenbaugh A; Diederich A; Core E
    Tex Rep Biol Med; 1980-1981; 40():313-22. PubMed ID: 7323976
    [No Abstract]   [Full Text] [Related]  

  • 3. New Approaches to the therapy of sickle cell disease.
    Luskey KL; Schechter AN; Hercules JI
    Tex Rep Biol Med; 1980-1981; 40():305-12. PubMed ID: 6172868
    [No Abstract]   [Full Text] [Related]  

  • 4. The increasing complexity of sickle cell anemia.
    Warth JA; Rucknagel DL
    Prog Hematol; 1983; 13():25-47. PubMed ID: 6199811
    [No Abstract]   [Full Text] [Related]  

  • 5. Hematology clinic. Sickle cell disease.
    Ngo D; Steinberg M
    Hematology; 2014 Jun; 19(4):244-5. PubMed ID: 24666152
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurements of red cell deformability and hydration reflect HbF and HbA
    Parrow NL; Tu H; Nichols J; Violet PC; Pittman CA; Fitzhugh C; Fleming RE; Mohandas N; Tisdale JF; Levine M
    Blood Cells Mol Dis; 2017 Jun; 65():41-50. PubMed ID: 28472705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of fifteen anti-sickling agents.
    Chang H; Ewert SM; Bookchin RM; Nagel RL
    Blood; 1983 Apr; 61(4):693-704. PubMed ID: 6338971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (third of three parts).
    Dean J; Schechter AN
    N Engl J Med; 1978 Oct; 299(16):863-70. PubMed ID: 692579
    [No Abstract]   [Full Text] [Related]  

  • 9. Seeking a way to alleviate sickle cell disease.
    Mitka M
    JAMA; 2002 Oct 23-30; 288(16):1970. PubMed ID: 12387636
    [No Abstract]   [Full Text] [Related]  

  • 10. The molecular basis of antisickling agents.
    Franklin IM; Huehns ER
    Trans R Soc Trop Med Hyg; 1980; 74(6):695-700. PubMed ID: 7210123
    [No Abstract]   [Full Text] [Related]  

  • 11. A view of the current status of antisickling therapy.
    Brewer GJ
    Am J Hematol; 1976; 1(1):121-8. PubMed ID: 790948
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of sickle cell disease. A historical and chronological literature review of the therapies applied since 1910.
    Aluoch JR
    Trop Geogr Med; 1984 Dec; 36(4):S1-26. PubMed ID: 6396910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hydroxyurea in sickle cell disease.
    Halsey C; Roberts IA
    Br J Haematol; 2003 Jan; 120(2):177-86. PubMed ID: 12542474
    [No Abstract]   [Full Text] [Related]  

  • 14. Should we still be focused on red cell hemoglobin F as the principal explanation for the salutary effect of hydroxyurea in sickle cell disease?
    Segel GB; Simon W; Lichtman MA
    Pediatr Blood Cancer; 2011 Jul; 57(1):8-9. PubMed ID: 21480473
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathophysiologically based drug treatment of sickle cell disease.
    Steinberg MH
    Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red cell membrane abnormalities in sickle cell anemia.
    Bookchin RM; Lew VL
    Prog Hematol; 1983; 13():1-23. PubMed ID: 6322226
    [No Abstract]   [Full Text] [Related]  

  • 17. Sickle cell anemia therapy: progress since Pauling.
    Schechter AN; Rodgers GP
    Science; 2000 Jan; 287(5453):592-3. PubMed ID: 10691539
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.
    Stuart J; Stone PC; Bilto YY; Keidan AJ
    J Clin Pathol; 1987 Oct; 40(10):1182-6. PubMed ID: 3119675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of methyl acetimidate as an extracorporeal antisickling agent.
    Chao TL; Berenfeld MR; Gabuzda TG
    Am J Pediatr Hematol Oncol; 1984; 6(1):55-8. PubMed ID: 6711765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapy of sickle-cell anemia.
    Lehmann H
    Prog Clin Biol Res; 1979; 34():361-8. PubMed ID: 531061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.